This shift could be significant in CRC because while IL-13 is important in tissue repair, it can also promote CRC tumor growth and metastasis, and can inhibit anti-tumor immunity by promoting a Th2-type microenvironment (47, 48). This evidence concerns the gene IL13 and neoplasm.